EPAS1 |
EPAS1, HIF2A, MOP2: Endothelial PAS domain-containing protein 1 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
6.82E3 |
Evidence |
|
ABCD3 |
ABCD3, PMP70, PXMP1: ATP-binding cassette sub-family D member 3 |
ABCD1 |
ABCD1, ALD: ATP-binding cassette sub-family D member 1 |
6.82E3 |
Evidence |
O
|
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
6.78E3 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
6.70E3 |
Evidence |
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
6.62E3 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
6.59E3 |
Evidence |
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
6.52E3 |
Evidence |
|
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
6.51E3 |
Evidence |
|
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
6.49E3 |
Evidence |
|
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
6.48E3 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
6.36E3 |
Evidence |
|
PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
6.34E3 |
Evidence |
|
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
6.34E3 |
Evidence |
|
RANBP1 |
RANBP1: Ran-specific GTPase-activating protein |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
6.34E3 |
Evidence |
O
|
PROC |
PROC: Vitamin K-dependent protein C precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
6.28E3 |
Evidence |
|
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
6.25E3 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
6.15E3 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
6.13E3 |
Evidence |
|
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
6.08E3 |
Evidence |
O
|
F10 |
F10: Coagulation factor X precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
6.03E3 |
Evidence |
|
PROC |
PROC: Vitamin K-dependent protein C precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
6.03E3 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
6.01E3 |
Evidence |
|
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
5.98E3 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
5.98E3 |
Evidence |
|
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
5.98E3 |
Evidence |
|